| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/28/2002 | EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 08/28/2002 | EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 08/28/2002 | EP1233950A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS |
| 08/28/2002 | EP1233949A2 5-substituted arylpyrimidines |
| 08/28/2002 | EP1233943A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 08/28/2002 | EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 08/28/2002 | EP1233781A1 Assays and therapies for latent viral infection |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233776A1 Urotensin-ii cyclic analogs |
| 08/28/2002 | EP1233774A1 Urotensin-ii analogs |
| 08/28/2002 | EP1233770A2 Phosphonate compounds |
| 08/28/2002 | EP1233767A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 08/28/2002 | EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 08/28/2002 | EP1233681A1 Phytosterol and phytostanol compositions |
| 08/28/2002 | EP1040106B1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 08/28/2002 | EP0918759B1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 08/28/2002 | EP0869785B1 4-hydroxycoumarin-3-carboxamides for the treatment of non-insulin dependent diabetes mellitus |
| 08/28/2002 | CN1366520A Medicine |
| 08/28/2002 | CN1366062A Recombination carrier and treating composition used in insulin dependent diabetes gene curing |
| 08/28/2002 | CN1366051A Modifying method and application of exilis protein gene |
| 08/28/2002 | CN1366038A Bioregulator for reconfiguring human immune function and its preparing process |
| 08/28/2002 | CN1365828A Medicine for treating diabetes |
| 08/28/2002 | CN1365823A Active full-component wheat spear extract and its microcapsule and preparing process |
| 08/28/2002 | CN1365815A Orally applied capsule 'Yejuzhi' |
| 08/28/2002 | CN1365719A Nano medicine 'Erdong' and its preparing process |
| 08/28/2002 | CN1365678A Nano medicine 'Yixintong' and its preparing process |
| 08/28/2002 | CN1365667A Use of phytanic acid for treating diabetes |
| 08/28/2002 | CN1089759C Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 08/28/2002 | CN1089601C Diabetes eliminating medicated string for fast curing diabetes |
| 08/28/2002 | CN1089584C Treatment for arteriosclerosis and vitiligoidea |
| 08/27/2002 | US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt |
| 08/27/2002 | US6441185 Method for producing thiazolidinediones, and new thiazolidinediones |
| 08/27/2002 | US6441184 Such as n-benzooxazol-2-yl-3-cyclopentyl-2-(4-methanesulfonyl -phenyl)-propionamide for increasing insulin secretion in the treatment of type ii diabetes |
| 08/27/2002 | US6441180 Tetrazolyl-phenyl actamide glucokinase activators |
| 08/27/2002 | US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity |
| 08/27/2002 | US6441168 Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 08/27/2002 | US6441153 Human carboxypeptidases and polynucleotides encoding the same |
| 08/27/2002 | US6441149 Isolated nucleic acids |
| 08/27/2002 | US6441048 Methods of treating affective disorders using derivatives of (-)-venlafaxine |
| 08/27/2002 | US6441036 Treating atherosclerosis and insulin resistance |
| 08/27/2002 | US6441015 Tetrazole compounds as thyroid receptor ligands |
| 08/27/2002 | US6441012 Chemical compounds |
| 08/27/2002 | US6441000 Compounds useful in therapy |
| 08/27/2002 | US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 08/27/2002 | US6440972 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| 08/27/2002 | US6440968 Use of maduraohtalazine derivatives as inhibitors of proinflammatory cytokines |
| 08/27/2002 | US6440966 Benzenesulfonamide derivatives and their use as MEK inhibitors |
| 08/27/2002 | US6440962 Cardiovascular disorders, antiischemic agents |
| 08/27/2002 | US6440958 Acrylic and propionic acid compounds, intermediates, processes, compositions, and methods |
| 08/27/2002 | US6440955 Anti-inflammatory agents |
| 08/27/2002 | US6440953 Use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. |
| 08/27/2002 | US6440930 Protein formulations |
| 08/27/2002 | US6440468 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | US6440413 Selectively destroying subunit a without destroying subunit b of cholera toxin; enzyme with preponderance of exocellular proteinase produced by a culture of streptomyces fradiae; hyperviscosity of intestinal, bronchial and/or genital mucus |
| 08/27/2002 | US6440387 For decreasing blood cholesterol levels, thereby decreasing risk for developing alzheimer's disease; for post menopausal women |
| 08/27/2002 | CA2167039C Alkylated (hetero)cyclic compounds; process for preparing the same and pharmaceutical compositions containing them |
| 08/27/2002 | CA2125888C Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
| 08/27/2002 | CA2101548C Acylamino-alkylidenhydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
| 08/22/2002 | WO2002064827A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | WO2002064795A2 Putative human enzymes |
| 08/22/2002 | WO2002064793A2 G protein-coupled receptor-like proteins and nucleics acids encoding same |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064791A2 Proteins and nucleic acids encoding same |
| 08/22/2002 | WO2002064784A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 08/22/2002 | WO2002064755A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064714A1 PRODUCTS CONTAINING $G(b)-GLUCAN |
| 08/22/2002 | WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 08/22/2002 | WO2002064627A2 Crystallization of igf-1 |
| 08/22/2002 | WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | WO2002064606A1 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 08/22/2002 | WO2002064601A1 Dicarba-closo-dodecarborane derivatives |
| 08/22/2002 | WO2002064592A1 Tricyclic crf receptor antagonists |
| 08/22/2002 | WO2002064589A1 Laulimalide derivatives |
| 08/22/2002 | WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof |
| 08/22/2002 | WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064550A1 Glucocorticoid receptor modulators |
| 08/22/2002 | WO2002064549A1 Ppar agonists |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
| 08/22/2002 | WO2002064543A2 Novel succinate salt of o-desmethyl-venlafaxine |
| 08/22/2002 | WO2002064210A2 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 08/22/2002 | WO2002064160A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/22/2002 | WO2002064138A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 08/22/2002 | WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/22/2002 | WO2002064134A2 Use of calcium indomethacin for the treatment of cyclo-oxygenase 2-mediated pathologies |
| 08/22/2002 | WO2002064130A1 Proliferative activator receptor (ppar) compounds |
| 08/22/2002 | WO2002064129A2 Compositions of biochemical compounds involved in bioenergy metabolism of cells |
| 08/22/2002 | WO2002064126A2 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | WO2002064125A2 Use of a farnesoid x receptor antagonist for treating hyperlipidemia |
| 08/22/2002 | WO2002064111A1 Vitamin/mineral complex |
| 08/22/2002 | WO2002064109A2 Mucoadhesive pharmaceutical formulations |
| 08/22/2002 | WO2002064094A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers |
| 08/22/2002 | WO2002045652A3 Tyrosine kinase inhibitors |
| 08/22/2002 | WO2002032893A3 Piperidine compounds as anti-allergic |
| 08/22/2002 | WO2002032377A3 Estrogen receptor modulators |
| 08/22/2002 | WO2002024204A3 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 08/22/2002 | WO2002024002A3 Food supplement |